Results 171 to 180 of about 29,839 (226)

ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development. [PDF]

Blood Adv
Andrieu GP, Hypolite G, Latiri M, Balducci E, Costa C, Verhoeyen E, Courgeon M, Allatif O, Nemazanyy I, Panasyuk G, Wellen K, Herranz D, Genestier L, Macintyre E, Asnafi V, Tesio M.   +15 more
europepmc   +1 more source

Hydroxycitrate-loaded exosomes demonstrate enhanced therapeutic efficacy against lung adenocarcinoma by inhibiting the metabolic enzyme ATP citrate lyase. [PDF]

Nanoscale Adv
Phutela K, Bal A, Singh N, Sharma S.
europepmc   +1 more source

Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation. [PDF]

Genes (Basel), 2021
Zheng W, Tasselli L, Li TM, Chua KF.
europepmc   +1 more source

Bioenergetics of protein transport into mitochondria [PDF]

, 1988
Döhren, H. von, Jaenicke, L., Kleinkauf, Horst, Neupert, Walter, Pfanner, Nikolaus   +4 more
core  

Role of ATP citrate lyase and its complementary partner on fatty acid synthesis in gastric cancer. [PDF]

Sci Rep
Li C, Liu W, Liu Y, Wang W, Deng W.
europepmc   +1 more source

Association of fatty acid synthase (FASN), ATP-citrate lyase (ACLY), and acyl-coenzyme A synthetase long-chain 4 (ACSL4) expression and human epidermal growth factor receptor 2 (HER2) status with metastasis and survival in breast cancer: a five-year follow-up. [PDF]

Res Pharm Sci
Dinarvand N, Pourfarzam M, Emadi M, Hashemiyan MK, Azizi R.   +4 more
europepmc   +1 more source

Serum proteome-wide identified ATP citrate lyase as a novel informative diagnostic and prognostic biomarker in pediatric sepsis: A pilot study. [PDF]

Immun Inflamm Dis, 2021
Wang C, Zhu X, Cui Y, Miao H, Xu Y, Xiong X, Tang X, Shao L, Zhang Y.   +8 more
europepmc   +1 more source

Brown fat ATP-citrate lyase links carbohydrate availability to thermogenesis and guards against metabolic stress. [PDF]

Nat Metab
Korobkina ED, Calejman CM, Haley JA, Kelly ME, Li H, Gaughan M, Chen Q, Pepper HL, Ahmad H, Boucher A, Fluharty SM, Lin TY, Lotun A, Peura J, Trefely S, Green CR, Vo P, Semenkovich CF, Pitarresi JR, Spinelli JB, Aydemir O, Metallo CM, Lynes MD, Jang C, Snyder NW, Wellen KE, Guertin DA.   +26 more
europepmc   +1 more source

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects. [PDF]

Drug Des Devel Ther
Liu Y, Yu C, Zhang Y, Xie Z, Wang Y, Qian H, Liang L, Liu Y, Chen Q, Jia J, Yan S, Lai X, Li W, Li J, Zhang Y, Nan F, Yu C.   +16 more
europepmc   +1 more source